FDA Device Intelligence
HomeMERIDIAN BIOSCIENCE, INC. › TRU RSV

TRU RSV

MERIDIAN BIOSCIENCE, INC. · Model 751330 · UDI-DI 00840733101847

GQG Prescription
1
510(k) clearances
29
Adverse events
3
Recalls
35
Facilities

Description

TRU RSV is a rapid, qualitative, lateral-flow immunoassay for the detection of Respiratory Syncytial Virus (RSV) antigens (fusion protein or nucleoprotein) in human nasal wash, nasopharyngeal aspirate, and nasal and nasopharyngeal swab samples. It is designed to be used by clinical laboratories to test specimens from symptomatic patients aged five years or less. A negative result does not preclude RSV infection. It is recommended that all negative test results be confirmed by cell culture. The results of this test are used in combination with other clinical tests and the patients’ conditions to diagnose RSV-associated infections.

Recalls

DateFirmReason
2007-03-28Binax, Inc. dba IMPDTip of the foam swab could detach from the shaft causing injury to the patient.
2004-02-18Binax, Inc.Pouch integrity compromised
2003-12-15Becton Dickinson & Co.Diagnostic test kit may exhibit false positive results.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.